Skip to main content
Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
19.03
0.00 (0.00%)
At close: Jan 22, 2025

TEVJF Revenue

Teva Pharmaceutical Industries had revenue of $4.33B in the quarter ending September 30, 2024, with 12.52% growth. This brings the company's revenue in the last twelve months to $16.77B, up 9.81% year-over-year. In the year 2023, Teva Pharmaceutical Industries had annual revenue of $15.85B with 6.17% growth.

Revenue (ttm)
16.77B
Revenue Growth
+9.81%
P/S Ratio
n/a
Revenue / Employee
453.30K
Employees
36,472
Market Cap
24.72B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 201916.89B-1.38B-7.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.79B
Veradigm 1.53B
SS Innovations International 16.04M
Elite Pharmaceuticals 71.17M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
BioStem Technologies 210.49M
Silence Therapeutics 21.77M
Revenue Rankings

Teva Pharmaceutical Industries News

More News